Duloxetine enhances PAX6 expression and suppresses innate immune responses in murine LPS-induced corneal inflammation

This publication has 52 references indexed in Scilit:

• A positive feedback cycle between the alarmin S100A8/A9 and NLRP3 inflammasome-GSDMD signalling reinforces the innate immune response in Candida albicans keratitis
  Inflammation Research, 2023
• Duloxetine ameliorates lipopolysaccharide-induced microglial activation by suppressing iNOS expression in BV-2 microglial cells
  Psychopharmacology, 2022
• Evaluation of the effects of duloxetine treatment on anterior segment parameters by optical coherence tomography
  International Ophthalmology, 2022
• Ritanserin, a potent serotonin 2A receptor antagonist, represses MEK/ERK signalling pathway to restore PAX6 production and function in aniridia-like cellular model
  Biochemical and Biophysical Research Communications, 2021
• Modeling of Aniridia-Related Keratopathy by CRISPR/Cas9 Genome Editing of Human Limbal Epithelial Cells and Rescue by Recombinant PAX6 Protein
  Stem Cells, 2018
• Molecular and Cellular Mechanisms of Antidepressant Action
  2012
• Analysis of Matrix Metalloproteinase Secretion by Macrophages
  2009
• Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation
  Depression and Anxiety, 2006
• Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo‐controlled clinical trials
  Human Psychopharmacology: Clinical and Experimental, 2005
• Macrophages Secrete Matrix Metalloproteinase 9 Covalently Linked to the Core Protein of Chondroitin Sulphate Proteoglycans
  Journal of Molecular Biology, 2000